Home › NCT07268118
Pain Control for Cervical Ripening Balloon
RecruitingPhase 2
Randomized Control Trial for Pain Control With Topical Lidocaine for Cervical Ripening Balloon Placement
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * Age ≥18 years * Gestational age ≥37 weeks * Viable pregnancy * Intact membranes * English speaking * Interested in cervical ripening balloon placement * Able to provide consent Exclusion Criteria: * Allergy or sensitivity to lidocaine * Patients that already have neuraxial anesthesia (i.e. spinal, epidural, combined spinal/epidural) * Known uterine or cervical anomalies
About the study
No standard of care exists for pain management during cervical ripening balloon placement. The purpose of this study is to evaluate if vaginal topical lidocaine reduces pain related to cervical ripening balloon placement during induction of labor.
What is being tested
- topical vaginal application lidocaine gel (drug)
Sponsor: Beth Israel Deaconess Medical Center · Participants: 110 · Started: May 13, 2026
Contact the study team
- Sarah Little, MD · Phone: 6176677000
Official record on ClinicalTrials.gov — NCT07268118
Locations in the U.S.
| Massachusetts | Beth Israel Deaconess Medical Center, Boston |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.